Siemens Medical Systems has become the second gamma camera vendor to win Food and DrugAdministration 510(k) clearance for a nonuniform attenuation correctionproduct. Siemens' Hoffman Estates, IL, nuclear medicine grouplast month got the FDA's imprimatur
Siemens Medical Systems has become the second gamma camera vendor to win Food and DrugAdministration 510(k) clearance for a nonuniform attenuation correctionproduct. Siemens' Hoffman Estates, IL, nuclear medicine grouplast month got the FDA's imprimatur to market the technique asan option for the open-configuration versions of its MultiSPECT2 and MultiSPECT 3 dual-head and triple-head gamma cameras. Siemenscompetitor Picker International was the first vendor to marketattenuation correction last year (SCAN 6/1/94).
The Siemens approach relies on offset fan-beam collimators,which have advantages over the centered fan-beam techniques usedin competing systems, according to Reinout Vogt, manager of newproduct development. A radioactive source is mounted to the sideof a detector rather than in the center, with the gamma rays detectedby the offset fan-beam collimator opposing the source. This increasesthe detector's effective field-of-view and avoids truncation artifacts,Vogt said.
The radioactive source used by the technique is americium,which has a half-life of 433 years and thus does not need to bereplaced for the life of the gamma camera. The vendor of the americiumsources has agreed to take them back when the camera is retired,Vogt said.
Siemens plans to begin shipping open-configuration MultiSPECT2 and MultiSPECT 3 cameras later this year. They can be linkedwith any DICOM 3.0-compatible workstation (SCAN 11/23/94).
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.